New FDA Warning Letters Show India’s Drugmakers Still in Trouble
White capsules are displayed for a photograph at a manufactuting plant in South Carolina, U.S. (Photographer: Ariana Lindquist/Bloomberg)

New FDA Warning Letters Show India’s Drugmakers Still in Trouble

(Bloomberg) -- Three major Indian drugmakers received warning letters from the U.S. health care watchdog in the last two months, highlighting that the country’s copycat drug sector is still plagued...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.